ExonHit to Participate in European Alzheimer's Research Effort | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – RNA-based diagnostics and drug developer ExonHit Therapeutics will provide transcriptomics analysis services and its SpliceArray to a European public and private-funded consortium that is focused on identifying new biomarkers for Alzheimer's disease, the Paris-based company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.